Public Employees Retirement System Of Ohio Jounce Therapeutics, Inc. Transaction History

Public Employees Retirement System Of Ohio

$22.6 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Dec 19, 2023	BUY	$0.64 - $1.99 $3,124 - $9,715	4,882 New	4,882 $5,000
Q4 2022 Feb 15, 2023	SELL	$0.64 - $1.99 $709 - $2,204	-1,108 Reduced 18.5%	4,882 $5,000
Q3 2022 Nov 15, 2022	SELL	$2.73 - $4.92 $35,490 - $63,960	-13,000 Reduced 68.46%	5,990 $14,000
Q2 2022 Aug 15, 2022	BUY	$2.8 - $7.67 $13,123 - $35,949	4,687 Added 32.77%	18,990 $58,000
Q4 2021 Feb 15, 2022	BUY	$7.11 - $9.64 $101,694 - $137,880	14,303 New	14,303 $119,000
Q1 2021 May 14, 2021	SELL	$6.73 - $13.87 $47,702 - $98,310	-7,088 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$2.91 - $8.7 $8,404 - $25,125	2,888 Added 68.76%	7,088 $34,000
Q3 2019 Nov 15, 2019	BUY	$3.33 - $4.93 $13,986 - $20,706	4,200 New	4,200 $14,000

Others Institutions Holding JNCE

# of Institutions

Shares Held

720K

Call Options Held

Put Options Held

View Full List

About Jounce Therapeutics, Inc.

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

More about JNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Account